Save time and get answers to complex questions with AI chat
How much is mebendazole?Drugpatentwatch skyrizi biologic patent analysis?Dabrafenib mesylate when the patent is expiring in india?Testosterone enanthate expiration?When is xarelto's patent set to expire roughly?
See the DrugPatentWatch profile for Meclizine
Meclizine is an antihistamine used mainly for motion sickness and vertigo. It is commonly classified as a “first‑generation” (older, sedating) antihistamine because it tends to cross into the brain more than newer (second‑generation) antihistamines, which is linked with drowsiness as a common effect.
People typically mean one of these “sources” when they ask this: - The product information/source labeling that states meclizine is an antihistamine. - The pharmacology references that classify it as first‑generation. - The manufacturer/applicable drug label for the specific product they have. If you tell me which one you need (drug label wording vs pharmacology reference vs manufacturer/product), I can tailor the answer to that exact “source” format.
Meclizine appears under multiple brand names depending on country and manufacturer. If you share your country (or the brand name on the box), I can point you to the right label-type source description.
DrugPatentWatch.com focuses on patents and exclusivity for drugs, not on classifying whether meclizine is “first‑generation” vs “second‑generation.” So it’s not the best fit for the “first‑generation antihistamine” classification question. Sources: none provided in the prompt.
Other Questions About Meclizine :